海泰新光跌1.96%，成交额5575.79万元，今日主力净流入-909.88万

Core Viewpoint - The company, Qindao Haitai New Light Technology Co., Ltd., is experiencing a decline in stock price while benefiting from the depreciation of the RMB and its status as a "specialized, refined, distinctive, and innovative" enterprise in the medical device sector [1][2][3]. Group 1: Company Performance - The company reported a revenue of 448 million yuan for the first nine months of 2025, representing a year-on-year growth of 40.47% [7]. - The net profit attributable to the parent company for the same period was 136 million yuan, with a year-on-year increase of 40.03% [7]. - The company's main business revenue composition includes 64.86% from medical endoscopes, 21.63% from optical products, 13.09% from maintenance services, and 0.42% from leasing [7]. Group 2: Market Position and Recognition - The company has a vertical integration capability in the medical device industry, covering core components, key equipment, and system integration [2]. - It has been recognized as a "specialized, refined, distinctive, and innovative" small giant enterprise, which is a prestigious title in China for companies excelling in niche markets and innovation [3]. - As of the 2024 annual report, overseas revenue accounted for 69.12% of total revenue, benefiting from the depreciation of the RMB [3]. Group 3: Stock and Trading Information - On November 28, the company's stock price fell by 1.96%, with a trading volume of 55.78 million yuan and a turnover rate of 1.04%, resulting in a total market capitalization of 5.339 billion yuan [1]. - The average trading cost of the stock is 46.61 yuan, with the stock price approaching a resistance level of 45.45 yuan, indicating potential for a price correction if this level is not surpassed [6]. - The main capital flow showed a net outflow of 9.09 million yuan today, with a continuous reduction in main capital over the past three days [4][5].